Kissei Pharmaceutical Past Earnings Performance
Past criteria checks 1/6
Kissei Pharmaceutical has been growing earnings at an average annual rate of 26.1%, while the Pharmaceuticals industry saw earnings growing at 1.6% annually. Revenues have been growing at an average rate of 0.3% per year. Kissei Pharmaceutical's return on equity is 6.2%, and it has net margins of 16.5%.
Key information
26.1%
Earnings growth rate
26.5%
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | 0.3% |
Return on equity | 6.2% |
Net Margin | 16.5% |
Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Kissei Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 73,717 | 12,198 | 19,797 | 10,391 |
30 Sep 23 | 71,607 | 12,880 | 19,763 | 10,391 |
30 Jun 23 | 70,521 | 12,158 | 20,234 | 10,391 |
31 Mar 23 | 67,493 | 10,528 | 20,304 | 10,391 |
31 Dec 22 | 66,931 | 12,769 | 20,428 | 10,363 |
30 Sep 22 | 65,857 | 10,581 | 21,555 | 10,363 |
30 Jun 22 | 65,031 | 10,912 | 20,369 | 10,363 |
31 Mar 22 | 65,381 | 12,921 | 19,923 | 10,363 |
31 Dec 21 | 66,934 | 5,664 | 21,682 | 9,626 |
30 Sep 21 | 69,148 | 6,555 | 20,749 | 9,626 |
30 Jun 21 | 69,618 | 7,204 | 20,555 | 9,626 |
31 Mar 21 | 69,044 | 5,285 | 19,607 | 9,626 |
31 Dec 20 | 66,877 | 5,715 | 18,400 | 10,767 |
30 Sep 20 | 63,970 | 5,063 | 18,820 | 10,767 |
30 Jun 20 | 63,196 | 2,530 | 19,774 | 10,767 |
31 Mar 20 | 63,234 | 2,817 | 21,133 | 10,767 |
31 Dec 19 | 65,594 | 4,753 | 17,519 | 15,711 |
30 Sep 19 | 68,180 | 4,294 | 21,036 | 15,711 |
30 Jun 19 | 70,545 | 4,752 | 22,088 | 15,711 |
31 Mar 19 | 72,297 | 5,481 | 22,577 | 15,711 |
31 Dec 18 | 72,474 | 5,263 | 24,217 | 14,179 |
30 Sep 18 | 73,087 | 8,102 | 20,844 | 14,179 |
30 Jun 18 | 73,014 | 9,685 | 20,770 | 14,179 |
31 Mar 18 | 74,009 | 9,045 | 23,080 | 14,179 |
31 Dec 17 | 73,887 | 8,735 | 24,178 | 13,877 |
30 Sep 17 | 72,459 | 8,116 | 24,749 | 13,877 |
30 Jun 17 | 71,396 | 6,993 | 25,151 | 13,877 |
31 Mar 17 | 71,706 | 7,726 | 23,379 | 13,877 |
31 Dec 16 | 72,154 | 6,401 | 25,193 | 14,106 |
30 Sep 16 | 73,533 | 8,108 | 23,515 | 14,106 |
30 Jun 16 | 73,774 | 8,734 | 22,456 | 14,106 |
31 Mar 16 | 71,294 | 8,165 | 22,528 | 14,106 |
31 Dec 15 | 71,239 | 8,521 | 21,788 | 14,488 |
30 Sep 15 | 69,095 | 6,608 | 22,543 | 14,488 |
30 Jun 15 | 70,945 | 7,161 | 23,406 | 14,488 |
31 Mar 15 | 70,110 | 7,165 | 22,417 | 14,488 |
31 Dec 14 | 69,666 | 7,829 | 23,784 | 11,298 |
30 Sep 14 | 73,090 | 9,817 | 23,697 | 11,298 |
30 Jun 14 | 69,934 | 8,935 | 23,058 | 11,298 |
31 Mar 14 | 70,399 | 9,093 | 22,781 | 11,298 |
31 Dec 13 | 69,335 | 9,365 | 23,010 | 10,312 |
30 Sep 13 | 65,089 | 6,982 | 22,546 | 10,312 |
30 Jun 13 | 64,420 | 6,003 | 22,322 | 10,312 |
Quality Earnings: KSPH.F has a large one-off gain of ¥11.9B impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: KSPH.F's current net profit margins (16.5%) are lower than last year (19.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KSPH.F's earnings have grown significantly by 26.1% per year over the past 5 years.
Accelerating Growth: KSPH.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: KSPH.F had negative earnings growth (-4.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-13.2%).
Return on Equity
High ROE: KSPH.F's Return on Equity (6.2%) is considered low.